Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...
This open-label study evaluated the efficacy and safety of a new leuprolide acetate 45 mg 6-month depot formulation in 151 men with prostate cancer who received 2 intramuscular injections administered ...
NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results